老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioLine Rx

3.25
-0.1900-5.52%
盘后：3.24-0.0100-0.31%16:05 EDT
成交量：1.84万
成交额：6.10万
市值：1,209.33万
市盈率：-0.70
高：3.43
开：3.43
低：3.24
收：3.44
数据加载中...
总览公司新闻公告
2021/01/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/11/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多